Your browser doesn't support javascript.
loading
Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.
Al-Aieshy, Fadiea; Malmström, Rickard E; Antovic, Jovan; Pohanka, Anton; Rönquist-Nii, Yuko; Berndtsson, Maria; Al-Khalili, Faris; Skeppholm, Mika.
Afiliação
  • Al-Aieshy F; Department of Medicine Solna, Karolinska Institutet & Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden. fadiea.al-aieshy@karolinska.se.
  • Malmström RE; Clinical Pharmacology, Drug Safety and Evaluation Sector, L7:03, Karolinska University Hospital Solna, -17176, Stockholm, SE, Sweden. fadiea.al-aieshy@karolinska.se.
  • Antovic J; Department of Medicine Solna, Karolinska Institutet & Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
  • Pohanka A; Department of Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institutet & Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Rönquist-Nii Y; Department of Laboratory Medicine Huddinge, Division of Clinical Pharmacology, Karolinska Institutet & Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
  • Berndtsson M; Department of Laboratory Medicine Huddinge, Division of Clinical Pharmacology, Karolinska Institutet & Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
  • Al-Khalili F; Department of Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institutet & Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Skeppholm M; Department of Clinical Sciences, Cardiology Unit, Karolinska Institutet, Danderyds Hospital, Stockholm Heart Center, Stockholm, Sweden.
Eur J Clin Pharmacol ; 72(6): 671-9, 2016 Jun.
Article em En | MEDLINE | ID: mdl-27066956
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Inibidores do Fator Xa / Rivaroxabana Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Inibidores do Fator Xa / Rivaroxabana Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia